Revvity, Inc
A health science company that makes the tools, instruments, and software used in drug discovery and medical diagnostics — from lab automation and reagents to newborn-screening tests that have checked hundreds of millions of babies. Its roots reach back to PerkinElmer, founded in 1937 by an investment banker and a court reporter who bonded over astronomy. In 2023 the life-sciences and diagnostics arm took the name Revvity, a blend of "revolutionize" and the Latin "vita," meaning life.
Granted 2.7K
Granted 2.3K
Granted 2.3K
Granted 2.3K
Granted 2.3K
Granted 2.3K
Granted 3.3K · Sold 80
Granted 2.3K
Granted 2.3K
Granted 2.3K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Michas Alexis PDirector · 2 transactions | +1% | 131.6K | 2.7K | — | — |
| Barrett PeterDirector · 2 transactions | +8.8% | 28.3K | 2.3K | — | — |
| Chapin Samuel R.Director · 2 transactions | +19% | 22.7K | 2.3K | — | — |
| Witney FrankDirector · 2 transactions | +4.8% | 22.1K | 2.3K | — | — |
| Witz PascaleDirector · 2 transactions | +7.4% | 14.7K | 2.3K | — | — |
| Vounatsos MichelDirector · 2 transactions | +8.7% | 12.7K | 2.3K | — | — |
| Gonzales AnitaVice President and CAO · 4 transactions | +75% | 7.3K | 3.3K | — | 80 |
| Klobuchar Michael ADirector · 2 transactions | +19.9% | 6.1K | 2.3K | — | — |
| Vandebroek Sophie V.Director · 2 transactions | +19.9% | 6.1K | 2.3K | — | — |
| McMurry-Heath MichelleDirector · 2 transactions | +24% | 5.2K | 2.3K | — | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -80 shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.